ResMed Inc. – State Reviewer

Companies

Analyst’s Sets ResMed Inc. (NYSE:RMD) New Target at $211.40: RMD is Now On A Buy List

ResMed Inc. (NYSE:RMD) has a beta of 0.29, a 12-month trailing P/E ratio of 75.69, and a growth ratio of 3.71. The stock’s Relative Strength

Industry

ResMed Inc. (RMD) moved up 2.16%: ResMed Inc. Price Paint Picture of volatility

ResMed Inc. (NYSE:RMD) has a beta of 0.29, a 12-month trailing P/E ratio of 67.85, and a growth ratio of 3.33. The stock’s Relative Strength

Markets

ResMed Inc. (RMD) moved down -47.36% from 52 weeks low: Is it Too Late to Be Bullish?

ResMed Inc. (NYSE:RMD) shares fell to a low of $202.00 before closing at $203.93. Intraday shares traded counted 0.42 million, which was 34.19% higher than

Markets

RMD Stock: ResMed Inc. (NYSE:RMD) Is Still Worth a Bite

ResMed Inc. (NYSE:RMD) Relative Strength Index (RSI) is 60.83, with weekly volatility at 1.91% and ATR at 4.48. The RMD stock’s 52-week price range has

Tag: ResMed Inc.

Analyst’s Sets ResMed Inc. (NYSE:RMD) New Target at $211.40: RMD is Now On A Buy List

ResMed Inc. (RMD) moved up 2.16%: ResMed Inc. Price Paint Picture of volatility

ResMed Inc. (RMD) moved down -47.36% from 52 weeks low: Is it Too Late to Be Bullish?

RMD Stock: ResMed Inc. (NYSE:RMD) Is Still Worth a Bite

Quick Links

Categories